The costs of coronavirus vaccines and their pricing.
作者信息
Light Donald W, Lexchin Joel
机构信息
School of Osteopathic Medicine, Rowan University, Stratford, NJ 08540, USA.
School of Health Policy and Management, Faculty of Health, York University, Toronto M3J 1P3, Canada.
出版信息
J R Soc Med. 2021 Nov;114(11):502-504. doi: 10.1177/01410768211053006. Epub 2021 Nov 3.
Abstract
摘要
相似文献
1
The costs of coronavirus vaccines and their pricing.新冠病毒疫苗的成本及其定价。
J R Soc Med. 2021 Nov;114(11):502-504. doi: 10.1177/01410768211053006. Epub 2021 Nov 3.
2
Just allocation of COVID-19 vaccines.2019冠状病毒病疫苗的合理分配
BMJ Glob Health. 2021 Feb;6(2). doi: 10.1136/bmjgh-2020-004812.
3
Covid-19: an economic perspective on vaccinating the world.新冠疫情：全球疫苗接种的经济视角
BMJ. 2021 Jun 15;373:n1498. doi: 10.1136/bmj.n1498.
4
COVID-19 vaccines pricing policy options for low-income and middle- income countries.低收入和中等收入国家的新冠疫苗定价政策选项
BMJ Glob Health. 2021 Mar;6(3). doi: 10.1136/bmjgh-2021-005347.
5
COVID vaccines to reach poorest countries in 2023 - despite recent pledges.尽管近期有承诺，但新冠疫苗要到2023年才能抵达最贫穷国家。
Nature. 2021 Jul;595(7867):342-343. doi: 10.1038/d41586-021-01762-w.
6
Challenges in the rollout of COVID-19 vaccines worldwide.全球新冠疫苗推广面临的挑战。
Lancet Respir Med. 2021 Apr;9(4):e42-e43. doi: 10.1016/S2213-2600(21)00129-6. Epub 2021 Mar 5.
7
It's time to consider a patent reprieve for COVID vaccines.是时候考虑暂缓新冠疫苗的专利了。
Nature. 2021 Apr;592(7852):7. doi: 10.1038/d41586-021-00863-w.
8
Is there light at the end of the Covid-19 tunnel?新冠疫情的隧道尽头会有曙光吗？
Rev Med Virol. 2021 May;31(3):e2173. doi: 10.1002/rmv.2173. Epub 2020 Oct 1.
9
The unequal scramble for coronavirus vaccines - by the numbers.新冠疫苗的不平等争夺——数据说明一切。
Nature. 2020 Aug;584(7822):506-507. doi: 10.1038/d41586-020-02450-x.
10
Survival of the Wealthiest?最富有者的生存？
EMBO J. 2020 Dec 1;39(23):e107227. doi: 10.15252/embj.2020107227. Epub 2020 Nov 18.
引用本文的文献
1
AI-driven epitope prediction: a system review, comparative analysis, and practical guide for vaccine development.人工智能驱动的表位预测：疫苗开发的系统综述、比较分析及实用指南
NPJ Vaccines. 2025 Aug 30;10(1):207. doi: 10.1038/s41541-025-01258-y.
2
Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review.药品及其他卫生技术定价与报销决策中公共投资考量机制：一项范围综述
Appl Health Econ Health Policy. 2025 Aug 27. doi: 10.1007/s40258-025-00994-5.
3
Developing the next-generation of adenoviral vector vaccines.开发下一代腺病毒载体疫苗。
Hum Vaccin Immunother. 2025 Dec;21(1):2514356. doi: 10.1080/21645515.2025.2514356. Epub 2025 Jul 1.
4
The role of the right valuation method in setting the firm's break-even price for mpox (and other) vaccines.正确估值方法在确定猴痘（及其他）疫苗公司盈亏平衡价格方面的作用。
BMJ Glob Health. 2025 May 28;10(5):e018390. doi: 10.1136/bmjgh-2024-018390.
5
N- to C-Glycoside Rearrangement of Uridine 5'-Phosphate in Two Enzymatic Steps for the Production of Pseudouridine 5'-Phosphate.尿苷5'-磷酸通过两个酶促步骤进行N到C糖苷重排以生成假尿苷5'-磷酸。
Biotechnol Bioeng. 2025 Sep;122(9):2456-2464. doi: 10.1002/bit.29037. Epub 2025 May 28.
6
Integrated Chemoenzymatic Synthesis of the mRNA Vaccine Building Block N-Methylpseudouridine Triphosphate.mRNA疫苗构建模块N-甲基假尿苷三磷酸的化学酶法集成合成
Angew Chem Int Ed Engl. 2025 Aug 18;64(34):e202506330. doi: 10.1002/anie.202506330. Epub 2025 Jul 4.
7
RNA Structure: Past, Future, and Gene Therapy Applications.RNA结构：过去、未来及基因治疗应用
Int J Mol Sci. 2024 Dec 26;26(1):110. doi: 10.3390/ijms26010110.
8
Investigating the influencing factors of vaccination decisions for newly developed and established vaccines: a comparative study based on latent class logit models in China.调查新型和已建立疫苗接种决策的影响因素：基于中国潜在类别逻辑模型的比较研究。
Front Public Health. 2024 Aug 29;12:1455718. doi: 10.3389/fpubh.2024.1455718. eCollection 2024.
9
Feline Infectious Peritonitis mRNA Vaccine Elicits Both Humoral and Cellular Immune Responses in Mice.猫传染性腹膜炎mRNA疫苗在小鼠中引发体液免疫和细胞免疫反应。
Vaccines (Basel). 2024 Jun 24;12(7):705. doi: 10.3390/vaccines12070705.
10
The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review.草药对新型冠状病毒肺炎患者住院时间及核酸转阴时间/率结局的疗效：一项系统评价
Front Pharmacol. 2024 May 30;15:1383359. doi: 10.3389/fphar.2024.1383359. eCollection 2024.
本文引用的文献
1
Profiteering from vaccine inequity: a crime against humanity?从疫苗不公平中牟取暴利：反人类罪？
BMJ. 2021 Aug 16;374:n2027. doi: 10.1136/bmj.n2027.
2
Beyond The High Prices Of Prescription Drugs: A Framework To Assess Costs, Resource Allocation, And Public Funding.超越处方药高价：评估成本、资源配置和公共资金的框架。
Health Aff (Millwood). 2021 Feb;40(2):281-288. doi: 10.1377/hlthaff.2020.00328.
3
Covid-19: Countries are learning what others paid for vaccines.新冠疫情：各国正在了解其他国家购买疫苗的花费情况。
BMJ. 2021 Jan 29;372:n281. doi: 10.1136/bmj.n281.
4
Manufacturing costs of HPV vaccines for developing countries.发展中国家HPV疫苗的制造成本。
Vaccine. 2016 Nov 21;34(48):5984-5989. doi: 10.1016/j.vaccine.2016.09.042. Epub 2016 Oct 19.
5
Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil.活减毒登革热疫苗的生产成本：巴西圣保罗布坦坦研究所的案例研究。
Vaccine. 2012 Jul 6;30(32):4892-6. doi: 10.1016/j.vaccine.2012.02.064. Epub 2012 Mar 8.
Zotero 插件